Merck, NIH Cannot Explain Higher Number Of AIDS Cases In HIV Vaccinated Individuals
This article was originally published in The Pink Sheet Daily
Executive Summary
In some instances, the vaccine may have led to an increase in HIV infections.
You may also be interested in...
Biotech Takes Electrifying Approach To Developing An HIV Vaccine
In the tumultuous quest to create an effective HIV vaccine, an approach that combines a DNA vaccine with a jolt of electricity looks to be a promising candidate in monkeys, but more data is needed in humans before breaking out the champagne, researchers say
Biotech Takes Electrifying Approach To Developing An HIV Vaccine
In the tumultuous quest to create an effective HIV vaccine, an approach that combines a DNA vaccine with a jolt of electricity looks to be a promising candidate in monkeys, but more data is needed in humans before breaking out the champagne, researchers say
Hemispherx Ampligen Filing Will Jumpstart NDA Clock
Biopharma accelerates evaluation of the Toll-like receptor-3 agonist as an adjuvant for HIV/AIDS and avian influenza vaccines.